NDC 84386-082-10 - Sacubitril and Valsartan
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 84386-082
- Requested NDC
- 84386-082-10
- Package NDCs from labels
- 84386-082-60, 84386-082-18, 84386-082-10, 84386-082-78
- Manufacturer
- Aurobindo Pharma Limited | APL HEALTHCARE LIMITED
- Effective date
- 2026-10-21
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Sacubitril and Valsartan - Aurobindo Pharma Limited | APL HEALTHCARE LIMITED | Aurobindo Pharma Limited | APL HEALTHCARE LIMITED | 2026-10-21 | Human Prescription Drug Label |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Cell Salts | CALC. FLUOR., CALC. PHOS., CALC.SULPH., FERRUM PHOSPHORICUM, KALI MUR., KALI PHOS., KALI SULPH., MAG. PHOS., NAT. MUR., NAT. PHOS., NAT.SULPHURICUM, SILICEA | Newton Laboratories, Inc. | 985a3341-0fe0-1dd6-e053-2a95a90ad2c5 | 2025-07-25 | Warnings | ETJ7Z6XBU4 |
| Dolce and Gabbana Everlast Foundation SPF 20 01N Light | OCTISALATE, OCTOCRYLENE, TITANIUM DIOXIDE, ZINC OXIDE | Dolce & Gabbana Beauty S.R.L | 2ccf4e45-4cec-417d-9f4c-28f376025f1d | 2025-07-25 | Warnings | 15FIX9V2JP |
| Sacubitril and Valsartan | SACUBITRIL AND VALSARTAN | Ascend Laboratories, LLC | a0f23b69-5a1b-4aa8-8f0c-5818bd609492 | 2025-07-24 | Boxed warning, Warnings, Adverse reactions | 1656349 1656354 17ERJ0MKGI 80M03YXJ7I |
| SILICA MARINA | SILICON DIOXIDE | Boiron | 3aada26e-6a8e-f545-e063-6394a90a9f80 | 2025-07-24 | ETJ7Z6XBU4 | |
| Sunscreen | TITANIUM DIOXIDE 6.8% | Baxter of California, LLC | 146030bc-2bf4-25ea-e063-6294a90a4613 | 2025-07-24 | Warnings | 15FIX9V2JP |
| Cell Salts | CALC. FLUOR., CALC. PHOS., CALC.SULPH., FERRUM PHOSPHORICUM, KALI MUR., KALI PHOS., KALI SULPH., MAG. PHOS., NAT. MUR., NAT. PHOS., NAT.SULPHURICUM, SILICEA | Newton Laboratories, Inc. | 7a1b4e96-c96f-6424-e053-2991aa0aef30 | 2025-07-24 | Warnings | ETJ7Z6XBU4 |
| Cell Salts | CALC. FLUOR., CALC. PHOS., CALC.SULPH., FERRUM PHOSPHORICUM, KALI MUR., KALI PHOS., KALI SULPH., MAG. PHOS., NAT. MUR., NAT. PHOS., NAT.SULPHURICUM, SILICEA | Newton Laboratories, Inc. | 7a1a9ef9-9a54-5f94-e053-2a91aa0ab477 | 2025-07-24 | Warnings | ETJ7Z6XBU4 |
| Sacubitril and Valsartan | SACUBITRIL AND VALSARTAN | Ascend Laboratories, LLC | 98d838f6-03a9-43e9-b8dd-8882c6df1631 | 2025-07-24 | Boxed warning, Warnings, Adverse reactions | 1656349 1656354 1656340 17ERJ0MKGI 80M03YXJ7I |
| Sacubitril and valsartan | SACUBITRIL AND VALSARTAN | Camber Pharmaceuticals, Inc. | 65a3e298-279d-4498-a7be-5f9ee5bc77d8 | 2025-07-23 | Boxed warning, Warnings, Adverse reactions | 1656349 1656354 1656340 17ERJ0MKGI 80M03YXJ7I |
| La Defense Broad Spectrum SPF 30 Mineral Sunscreen | ZINC OXIDE, TITANIUM DIOXIDE | Luzern Laboratories, Inc | 3f00befa-415d-415d-89e1-6ba8770ba51e | 2025-07-21 | Warnings | 15FIX9V2JP |
| Sacubitril and Valsartan | SACUBITRIL AND VALSARTAN | Novugen Pharma (USA) LLC | ec37696b-eaac-4c74-9328-94857ce998e5 | 2025-07-17 | Boxed warning, Warnings, Adverse reactions | 1656354 17ERJ0MKGI 80M03YXJ7I |
| Sacubitril and Valsartan | SACUBITRIL AND VALSARTAN | Biocon Pharma Inc. | 7de9b8e0-195a-b59e-7bbf-3e95c4096af9 | 2025-07-17 | Boxed warning, Warnings, Adverse reactions | 1656349 1656354 1656340 17ERJ0MKGI 80M03YXJ7I |
| Aller-Chord F | ACETALDEHYDE, ACETICUM AC, ARG NIT, CAFFEINUM, CALC SULPH, CITRICUM AC, CORTISONE ACETICUM, ECHINACEA PURP, FOLLICULINUM, FRAGARIA, FUMARICUM AC, GALLICUM AC, GLANDULA SUPRARENALIS SUIS, HEPAR SUIS, HISTAMINUM HYDROCHLORICUM, HYDRANGEA, LAC VAC, LECITHIN, LIMULUS, LYCOPERSICUM, LYCOPODIUM, NAT BICARB, NAT MUR, NUX VOM, PARAFFINUM, PHOSPHORICUM AC, SACCHARUM OFF, SILICEA, TARTARICUM AC, TORULA CEREVISIAE. | Energetix Corporation | ff4eb7b2-8272-4bd3-99a9-7e589b30d59a | 2025-07-15 | Warnings | ETJ7Z6XBU4 |
| DENTAL-CHORD | ACETICUM ACIDUM, AMMONIUM MURIATICUM, ARGENTUM METALLICUM, AURUM METALLICUM, CALCAREA FLUORICA, CALCAREA PHOSPHORICA, CARBOLICUM ACIDUM, CITRUS LIMONUM, CUPRUM METALLICUM, FERRUM METALLICUM, GLYCYRRHIZA GLABRA, LAPPA MAJOR, MEDULLA OSSIS SUIS, MERCURIUS SOLUBILIS, MYRRHA, NATRUM FLUORATUM, PALLADIUM METALLICUM, PHOSPHORICUM ACIDUM, PHYTOLACCA DECANDRA, SELENIUM METALLICUM, SILICEA, STANNUM METALLICUM, STAPHYSAGRIA, STILLINGIA SYLVATICA, TRIFOLIUM PRATENSE, X-RAY, ZINCUM OXYDATUM | Energetix Corporation | 6c9ba926-7c35-49fd-94d8-988ca0bb772c | 2025-07-15 | Warnings | ETJ7Z6XBU4 |
| Amarte ULTRA VEIL Daily | SUNSCREEN | Amarte USA LLC | 39e9ca98-d0e8-6b8f-e063-6394a90aa366 | 2025-07-15 | Warnings | 15FIX9V2JP |
| Amarte ULTRA VEIL BB Fair | SUNSCREEN | Amarte USA LLC | 39e87950-4103-c2eb-e063-6394a90a0552 | 2025-07-15 | Warnings | 15FIX9V2JP |
| Endocrinpath | ALFALFA, BORAGO OFFICINALIS, CALCAREA CARBONICA, CEANOTHUS AMERICANUS, CITRICUM ACIDUM, FUCUS VESICULOSUS, GINKGO BILOBA, GLANDULA SUPRARENALIS SUIS, GLYCYRRHIZA GLABRA, HYDROCOTYLE ASIATICA, HYPOTHALAMUS (BOVINE), KALI PHOSPHORICUM, PANCREAS SUIS, PHYTOLACCA DECANDRA, PITUITARUM POSTERIUM (BOVINE), SARSAPARILLA (SMILAX REGELII), SILICEA, SYZYGIUM JAMBOLANUM, TARAXACUM OFFICINALE, THYROIDINUM (BOVINE) | Energetix Corporation | 70f84941-b8a1-48f4-9c05-554e554f0049 | 2025-07-11 | Warnings | ETJ7Z6XBU4 |
| Sacubitril and Valsartan Sacubitril and Valsartan | SACUBITRIL AND VALSARTAN | Dr. Reddy's Laboratories Inc. | f4789255-b59b-544b-bbbe-2edd07da6079 | 2025-07-08 | Boxed warning, Warnings, Adverse reactions | 1656349 1656354 1656340 17ERJ0MKGI 80M03YXJ7I |
| sacubitril and valsartan | SACUBITRIL AND VALSARTAN | Zydus Pharmaceuticals USA Inc. | 4ed0dbe4-8752-43c5-8c28-17c9638a52d6 | 2025-07-08 | Boxed warning, Warnings, Adverse reactions | 1656349 1656354 1656340 17ERJ0MKGI 80M03YXJ7I |
| sacubitril and valsartan | SACUBITRIL AND VALSARTAN | Zydus Lifesciences Limited | 4c871c01-0564-411f-87e2-478aa42503cf | 2025-07-08 | 1656349 1656354 1656340 17ERJ0MKGI 80M03YXJ7I |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.